What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Thomas A. D'Amico mostly deals with Surgery, Lung cancer, Internal medicine, Oncology and Thoracotomy.
His Surgery research is multidisciplinary, incorporating perspectives in Anesthesia and Pneumonectomy.
His Lung cancer research incorporates themes from Stage and Single Center.
The Oncology study combines topics in areas such as Cancer, Targeted therapy, Epidermal growth factor receptor, Pathology and Radiation therapy.
His Cancer research incorporates elements of Esophagus and Dissection.
His Radiation therapy research includes themes of Clinical trial and Chemotherapy.
His most cited work include:
- Non–Small Cell Lung Cancer (1231 citations)
- Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology (645 citations)
- Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database (497 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Surgery, Lung cancer, Internal medicine, Oncology and Cancer.
He interconnects Pneumonectomy and Hazard ratio in the investigation of issues within Surgery.
His Lung cancer study incorporates themes from Radiation therapy, Radiology, Induction chemotherapy and Retrospective cohort study.
As part of his studies on Internal medicine, Thomas A. D'Amico often connects relevant subjects like Gastroenterology.
His Oncology research is multidisciplinary, relying on both Combined Modality Therapy, Targeted therapy, Clinical trial and Disease.
His Cardiothoracic surgery research is multidisciplinary, incorporating elements of General surgery and VATS lobectomy.
He most often published in these fields:
- Surgery (46.91%)
- Lung cancer (36.67%)
- Internal medicine (34.12%)
What were the highlights of his more recent work (between 2019-2021)?
- Proportional hazards model (8.96%)
- Cancer (16.42%)
- Lung cancer (36.67%)
In recent papers he was focusing on the following fields of study:
Thomas A. D'Amico focuses on Proportional hazards model, Cancer, Lung cancer, Surgery and Hazard ratio.
His research integrates issues of Retrospective cohort study, Oncology and Cohort in his study of Proportional hazards model.
Thomas A. D'Amico has included themes like Interquartile range, Chemotherapy and MEDLINE in his Oncology study.
The concepts of his Lung cancer study are interwoven with issues in Tumor size, Thoracotomy, Odds ratio and Wedge resection.
His study in Stage, Perioperative and Propensity score matching is carried out as part of his Surgery studies.
His biological study spans a wide range of topics, including Survival rate and Pneumonectomy.
Between 2019 and 2021, his most popular works were:
- A National Analysis of Short-term Outcomes and Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Clinical Stage II Non-Small-Cell Lung Cancer. (13 citations)
- Impact of Positive Margins and Radiation After Tracheal Adenoid Cystic Carcinoma Resection on Survival (7 citations)
- The immunotherapeutic landscape in non-small cell lung cancer and its surgical horizons. (6 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Thomas A. D'Amico mainly focuses on Proportional hazards model, Cancer, Lung cancer, Hazard ratio and Internal medicine.
His Proportional hazards model study is related to the wider topic of Surgery.
In the subject of general Surgery, his work in Surgical approach, Perioperative and Thymoma is often linked to Thymectomy, thereby combining diverse domains of study.
His work on Non small cell as part of general Lung cancer study is frequently connected to Text mining, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His research in Hazard ratio intersects with topics in Adjuvant therapy, Esophageal cancer, Wedge resection and Stage.
His Internal medicine study typically links adjacent topics like Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
